About Institute of Hematology and Transfusiology of the UAMS Department of blood diseases
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Institute of Hematology and Transfusiology of the UAMS Department of blood diseases
During the past decade, Institute of Hematology and Transfusiology of the UAMS Department of blood diseases conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Institute of Hematology and Transfusiology of the UAMS Department of blood diseases
According to Clinical.Site data, the most researched conditions in "Institute of Hematology and Transfusiology of the UAMS Department of blood diseases" are
"Multiple Myeloma" (2 trials) and "Newly Diagnosed Multiple Myeloma" (1 trials). Many other conditions were trialed in "Institute of Hematology and Transfusiology of the UAMS Department of blood diseases" in a lesser frequency.
Clinical Trials Intervention Types at Institute of Hematology and Transfusiology of the UAMS Department of blood diseases
Most popular intervention types in "Institute of Hematology and Transfusiology of the UAMS Department of blood diseases" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Aspirin" (1 trials), "CC-5013" (1 trials), "CC-5013 plus dexamethasone" (1 trials), "Dexamethasone plus Placebo" (1 trials) and "Lenalidomide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Institute of Hematology and Transfusiology of the UAMS Department of blood diseases
The vast majority of trials in "Institute of Hematology and Transfusiology of the UAMS Department of blood diseases" are
3 trials for "All" genders.
Clinical Trials Status at Institute of Hematology and Transfusiology of the UAMS Department of blood diseases
Currently, there are NaN active trials in "Institute of Hematology and Transfusiology of the UAMS Department of blood diseases".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Institute of Hematology and Transfusiology of the UAMS Department of blood diseases,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Institute of Hematology and Transfusiology of the UAMS Department of blood diseases, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".